Fermenta Biotec.

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE225B01021
NSEID:
BSEID: 506414

INR

351.15

10.8 (3.17%)

BSENSE

Dec 15

BSE+NSE Vol: 93.56 k

{
  "main_header": {
    "sid": 261671,
    "name": "Fermenta Biotec.",
    "stock_name": "Fermenta Biotec.",
    "full_name": "Fermenta Biotech Ltd",
    "name_url": "stocks-analysis/fermenta-biotec",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "351.15",
    "chg": 10.8,
    "chgp": "3.17%",
    "dir": 1,
    "prev_price": "340.35",
    "mcapval": "972.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 506414,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE225B01021",
    "curr_date": "Dec 15",
    "curr_time": "",
    "bse_nse_vol": "93.56 k",
    "exc_status": "Active",
    "traded_date": "Dec 15, 2025",
    "traded_date_str": "2025 12 15",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/fermenta-biotec-261671-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Fermenta Biotec. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-fermenta-biotec-fallingrising-3756820",
        "imagepath": "",
        "date": "2025-12-12 00:56:45",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Short-Term Price Momentum and Market Outperformance</strong></p>\n<p>Fermenta Biotec’s recent price action has been notably robust. Over the past week, the stock has gained 21.02%, sharply outperforming the Sensex, which declined by 0.52% during the same period. This positive momentum extends over the last month as well, with the stock appreciating 19.68% compared to the Sensex’s modest 1.13% rise. Such outperformance indicates strong buying interest and renewed confidence among investors in the near term.</p>\n<p>The stock’s upward trajectory is further underscored by its three consecutive days of gains, during which it has delivered a cumulative return of 20.95%. On 11-Dec, the share price touched an intraday high of ₹325, marking an 8.14% increase from the day’s low of ₹294.1. The wide intr..."
      },
      {
        "title": "Fermenta Biotech Sees Shift in Price Momentum Amid Mixed Technical Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fermenta-biotech-sees-mixed-technical-signals-amid-price-momentum-shift-3754620",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/FermentaBiotech_technicaldot_3754620.png",
        "date": "2025-12-10 08:02:25",
        "description": "Fermenta Biotech has experienced a notable shift in its price momentum, reflecting a complex interplay of technical indicators that suggest a transition from bearish to mildly bearish trends. The stock’s recent price movements and technical signals provide a nuanced picture for investors navigating the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Fermenta Biotec. Sees Revision in Market Evaluation Amid Mixed Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/fermenta-biotec-downgraded-to-sell-by-marketsmojo-amid-weak-fundamentals-3737190",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/FermentaBiotec_mojoScore_3737190.png",
        "date": "2025-11-30 10:24:23",
        "description": "Fermenta Biotec., a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting shifts in its fundamental and technical outlook. This adjustment follows a detailed reassessment of the company’s quality, valuation, financial trends, and technical indicators, providing investors with a nuanced perspective on its current standing."
      },
      {
        "title": "Fermenta Biotech Faces Bearish Technical Trends Amid Mixed Performance Indicators",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fermenta-biotechs-technical-trend-changes-from-mildly-bearish-to-bearish-amid-stock-price-decline-3710092",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/FermentaBiotech_technicaldot_3710092.png",
        "date": "2025-11-18 08:03:45",
        "description": "Fermenta Biotech, a microcap in the Pharmaceuticals and Biotechnology sector, has seen its stock price decline recently, reflecting mixed performance against the Sensex. While it has outperformed the index monthly and over three years, year-to-date results show significant challenges, necessitating close monitoring of market conditions."
      },
      {
        "title": "Why is Fermenta Biotec. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-fermenta-biotec-fallingrising-3708338",
        "imagepath": "",
        "date": "2025-11-17 22:24:03",
        "description": "As of 17-Nov, Fermenta Biotech Ltd's stock is currently priced at 276.80, reflecting a decline of 15.05 points or 5.16%. The stock has been underperforming, having fallen consecutively for the last two days with a total drop of 5.19%. It opened the day with a loss of 2.18% and reached an intraday low of Rs 274.5, which is a decrease of 5.94%. The stock's performance over the past week shows a slight decline of 0.18%, while it has gained 5.07% over the past month. However, year-to-date, it is down 23.95%, contrasting sharply with the Sensex, which has increased by 8.72%. There is a notable decrease in investor participation, with delivery volume dropping by 62.9% compared to the five-day average, indicating a lack of confidence among investors.\n\nBroader Market Context: In the context of the broader market, Fermenta Biotech's recent performance has been unfavorable compared to the Sensex, which has gained 1.6..."
      },
      {
        "title": "Is Fermenta Biotec. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-fermenta-biotec-technically-bullish-or-bearish-3700156",
        "imagepath": "",
        "date": "2025-11-14 08:10:47",
        "description": "As of 13 November 2025, the technical trend for Fermenta Biotec has changed from bearish to mildly bearish. The current stance is mildly bearish, primarily driven by the weekly MACD and KST indicators, both of which are bearish. The daily moving averages also reflect a bearish sentiment. However, the monthly Bollinger Bands indicate a bullish outlook, suggesting some potential for upward movement. The Dow Theory shows a mildly bullish signal on the weekly timeframe, but overall, the mixed signals across different indicators suggest a cautious approach...."
      },
      {
        "title": "Fermenta Biotech Faces Mixed Technical Trends Amid Market Evaluation Revision",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/fermenta-biotechs-technical-trend-shifts-from-bearish-to-mildly-bearish-amid-price-increase-3700519",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/FermentaBiotech_technicaldot_3700519.png",
        "date": "2025-11-14 08:01:41",
        "description": "Fermenta Biotech, a microcap in the Pharmaceuticals and Biotechnology sector, has recently revised its evaluation amid fluctuating market conditions. The stock has seen a year-to-date decline, contrasting with the Sensex's performance, while its three-year returns have outpaced the index, indicating a complex market position."
      },
      {
        "title": "Why is Fermenta Biotec. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-fermenta-biotec-fallingrising-3698610",
        "imagepath": "",
        "date": "2025-11-13 22:26:11",
        "description": "As of 13-Nov, Fermenta Biotech Ltd's stock price is currently at 291.15, reflecting an increase of 5.8, or 2.03%. The stock has shown a strong performance today, having outperformed its sector by 1.82% and achieving a consecutive gain over the last two days, resulting in an overall return of 8.84% during this period. It opened with a notable gain of 3.26% and reached an intraday high of Rs 298.9, indicating positive momentum. Additionally, the stock's delivery volume has significantly increased, rising by 187.2% compared to the 5-day average, which suggests heightened investor interest. However, the stock's year-to-date performance remains down by 20.00%, and it has underperformed against the benchmark over the longer term, particularly in the 1-month and 1-year periods.\n\nBroader Market Context: In the short term, Fermenta Biotech's stock has outperformed the Sensex, which has increased by 1.40% over the pa..."
      },
      {
        "title": "How has been the historical performance of Fermenta Biotec.?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-fermenta-biotec-3694582",
        "imagepath": "",
        "date": "2025-11-12 23:47:13",
        "description": "Answer:\nThe historical performance of Fermenta Biotec shows a fluctuating trend over the years, with significant changes in net sales, profits, and overall financial health.\n\nBreakdown:\nFermenta Biotec's net sales increased from 335.66 Cr in Mar'24 to 469.48 Cr in Mar'25, marking a notable recovery from previous years. The total operating income followed a similar trend, rising to 469.48 Cr in Mar'25 from 335.66 Cr in Mar'24. However, total expenditure also increased, reaching 359.68 Cr in Mar'25, up from 308.15 Cr in Mar'24. This led to an operating profit (PBDIT) of 121.62 Cr in Mar'25, a substantial increase from 39.32 Cr in the previous year. Profit before tax turned positive at 83.21 Cr in Mar'25, compared to a loss of 9.87 Cr in Mar'24, resulting in a profit after tax of 76.40 Cr, a significant turnaround from the loss of 24.01 Cr in Mar'24. The company's total assets increased to 585.83 Cr in Mar'25 ..."
      }
    ],
    "total": 512,
    "sid": "261671",
    "stock_news_url": "https://www.marketsmojo.com/news/fermenta-biotech-261671"
  },
  "announcements": [
    {
      "caption": "Update On Capacity Addition At Dahej Facility.",
      "datetime": "10-Dec-2025",
      "details": "Update on capacity addition at Dahej facility.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "10-Dec-2025",
      "details": "Intimation of investor meeting.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Raising of Funds",
      "datetime": "10-Dec-2025",
      "details": "The Board approved proposal for raising of funds.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Fermenta Biotech Ltd has declared <strong>50%</strong> dividend, ex-date: 06 Aug 25",
          "dt": "2025-08-06",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Fermenta Biotech Ltd has announced <strong>5:5</strong> stock split, ex-date: 08 Aug 18",
          "dt": "2018-08-08",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Fermenta Biotech Ltd has announced <strong>2:1</strong> bonus issue, ex-date: 13 Feb 20",
          "dt": "2020-02-13",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Fermenta Biotec. falling/rising?

2025-12-12 00:56:45

Short-Term Price Momentum and Market Outperformance

Fermenta Biotec’s recent price action has been notably robust. Over the past week, the stock has gained 21.02%, sharply outperforming the Sensex, which declined by 0.52% during the same period. This positive momentum extends over the last month as well, with the stock appreciating 19.68% compared to the Sensex’s modest 1.13% rise. Such outperformance indicates strong buying interest and renewed confidence among investors in the near term.

The stock’s upward trajectory is further underscored by its three consecutive days of gains, during which it has delivered a cumulative return of 20.95%. On 11-Dec, the share price touched an intraday high of ₹325, marking an 8.14% increase from the day’s low of ₹294.1. The wide intr...

Fermenta Biotech Sees Shift in Price Momentum Amid Mixed Technical Signals

2025-12-10 08:02:25

Fermenta Biotech has experienced a notable shift in its price momentum, reflecting a complex interplay of technical indicators that suggest a transition from bearish to mildly bearish trends. The stock’s recent price movements and technical signals provide a nuanced picture for investors navigating the Pharmaceuticals & Biotechnology sector.

Fermenta Biotec. Sees Revision in Market Evaluation Amid Mixed Financial Signals

2025-11-30 10:24:23

Fermenta Biotec., a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting shifts in its fundamental and technical outlook. This adjustment follows a detailed reassessment of the company’s quality, valuation, financial trends, and technical indicators, providing investors with a nuanced perspective on its current standing.

Fermenta Biotech Faces Bearish Technical Trends Amid Mixed Performance Indicators

2025-11-18 08:03:45

Fermenta Biotech, a microcap in the Pharmaceuticals and Biotechnology sector, has seen its stock price decline recently, reflecting mixed performance against the Sensex. While it has outperformed the index monthly and over three years, year-to-date results show significant challenges, necessitating close monitoring of market conditions.

Why is Fermenta Biotec. falling/rising?

2025-11-17 22:24:03

As of 17-Nov, Fermenta Biotech Ltd's stock is currently priced at 276.80, reflecting a decline of 15.05 points or 5.16%. The stock has been underperforming, having fallen consecutively for the last two days with a total drop of 5.19%. It opened the day with a loss of 2.18% and reached an intraday low of Rs 274.5, which is a decrease of 5.94%. The stock's performance over the past week shows a slight decline of 0.18%, while it has gained 5.07% over the past month. However, year-to-date, it is down 23.95%, contrasting sharply with the Sensex, which has increased by 8.72%. There is a notable decrease in investor participation, with delivery volume dropping by 62.9% compared to the five-day average, indicating a lack of confidence among investors. Broader Market Context: In the context of the broader market, Fermenta Biotech's recent performance has been unfavorable compared to the Sensex, which has gained 1.6...

Is Fermenta Biotec. technically bullish or bearish?

2025-11-14 08:10:47

As of 13 November 2025, the technical trend for Fermenta Biotec has changed from bearish to mildly bearish. The current stance is mildly bearish, primarily driven by the weekly MACD and KST indicators, both of which are bearish. The daily moving averages also reflect a bearish sentiment. However, the monthly Bollinger Bands indicate a bullish outlook, suggesting some potential for upward movement. The Dow Theory shows a mildly bullish signal on the weekly timeframe, but overall, the mixed signals across different indicators suggest a cautious approach....

Fermenta Biotech Faces Mixed Technical Trends Amid Market Evaluation Revision

2025-11-14 08:01:41

Fermenta Biotech, a microcap in the Pharmaceuticals and Biotechnology sector, has recently revised its evaluation amid fluctuating market conditions. The stock has seen a year-to-date decline, contrasting with the Sensex's performance, while its three-year returns have outpaced the index, indicating a complex market position.

Why is Fermenta Biotec. falling/rising?

2025-11-13 22:26:11

As of 13-Nov, Fermenta Biotech Ltd's stock price is currently at 291.15, reflecting an increase of 5.8, or 2.03%. The stock has shown a strong performance today, having outperformed its sector by 1.82% and achieving a consecutive gain over the last two days, resulting in an overall return of 8.84% during this period. It opened with a notable gain of 3.26% and reached an intraday high of Rs 298.9, indicating positive momentum. Additionally, the stock's delivery volume has significantly increased, rising by 187.2% compared to the 5-day average, which suggests heightened investor interest. However, the stock's year-to-date performance remains down by 20.00%, and it has underperformed against the benchmark over the longer term, particularly in the 1-month and 1-year periods. Broader Market Context: In the short term, Fermenta Biotech's stock has outperformed the Sensex, which has increased by 1.40% over the pa...

How has been the historical performance of Fermenta Biotec.?

2025-11-12 23:47:13

Answer: The historical performance of Fermenta Biotec shows a fluctuating trend over the years, with significant changes in net sales, profits, and overall financial health. Breakdown: Fermenta Biotec's net sales increased from 335.66 Cr in Mar'24 to 469.48 Cr in Mar'25, marking a notable recovery from previous years. The total operating income followed a similar trend, rising to 469.48 Cr in Mar'25 from 335.66 Cr in Mar'24. However, total expenditure also increased, reaching 359.68 Cr in Mar'25, up from 308.15 Cr in Mar'24. This led to an operating profit (PBDIT) of 121.62 Cr in Mar'25, a substantial increase from 39.32 Cr in the previous year. Profit before tax turned positive at 83.21 Cr in Mar'25, compared to a loss of 9.87 Cr in Mar'24, resulting in a profit after tax of 76.40 Cr, a significant turnaround from the loss of 24.01 Cr in Mar'24. The company's total assets increased to 585.83 Cr in Mar'25 ...

View All News